nodes	percent_of_prediction	percent_of_DWPC	metapath
Lapatinib—ERBB4—gallbladder cancer	0.409	0.479	CbGaD
Lapatinib—ERBB2—gallbladder cancer	0.302	0.354	CbGaD
Lapatinib—EGFR—gallbladder cancer	0.143	0.167	CbGaD
Lapatinib—ERBB2—gall bladder—gallbladder cancer	0.00396	0.132	CbGeAlD
Lapatinib—Gefitinib—ERBB3—gallbladder cancer	0.0033	0.691	CrCbGaD
Lapatinib—TAP1—pancreas—gallbladder cancer	0.0025	0.0833	CbGeAlD
Lapatinib—PIK3C2B—pancreas—gallbladder cancer	0.00235	0.0782	CbGeAlD
Lapatinib—ERBB2—epithelium—gallbladder cancer	0.00205	0.0683	CbGeAlD
Lapatinib—ERBB4—epithelium—gallbladder cancer	0.00205	0.0683	CbGeAlD
Lapatinib—ERBB2—pancreas—gallbladder cancer	0.00183	0.0608	CbGeAlD
Lapatinib—PI4KB—pancreas—gallbladder cancer	0.00171	0.057	CbGeAlD
Lapatinib—TAP1—liver—gallbladder cancer	0.00159	0.053	CbGeAlD
Lapatinib—PIK3C2B—liver—gallbladder cancer	0.00149	0.0498	CbGeAlD
Lapatinib—Gefitinib—EGFR—gallbladder cancer	0.00148	0.31	CrCbGaD
Lapatinib—TAP1—lymph node—gallbladder cancer	0.00122	0.0406	CbGeAlD
Lapatinib—ERBB2—liver—gallbladder cancer	0.00116	0.0387	CbGeAlD
Lapatinib—PIK3C2B—lymph node—gallbladder cancer	0.00114	0.0382	CbGeAlD
Lapatinib—PI4KB—liver—gallbladder cancer	0.00109	0.0363	CbGeAlD
Lapatinib—EGFR—liver—gallbladder cancer	0.000984	0.0328	CbGeAlD
Lapatinib—ERBB2—lymph node—gallbladder cancer	0.00089	0.0297	CbGeAlD
Lapatinib—PI4KB—lymph node—gallbladder cancer	0.000834	0.0278	CbGeAlD
Lapatinib—EGFR—lymph node—gallbladder cancer	0.000755	0.0252	CbGeAlD
Lapatinib—CYP3A5—pancreas—gallbladder cancer	0.000448	0.0149	CbGeAlD
Lapatinib—CYP2C19—liver—gallbladder cancer	0.000362	0.0121	CbGeAlD
Lapatinib—CYP2C8—liver—gallbladder cancer	0.000316	0.0105	CbGeAlD
Lapatinib—CYP3A5—liver—gallbladder cancer	0.000285	0.00949	CbGeAlD
Lapatinib—ABCB1—epithelium—gallbladder cancer	0.000267	0.0089	CbGeAlD
Lapatinib—ABCB1—pancreas—gallbladder cancer	0.000238	0.00793	CbGeAlD
Lapatinib—CYP3A4—liver—gallbladder cancer	0.000214	0.00713	CbGeAlD
Lapatinib—ABCB1—liver—gallbladder cancer	0.000151	0.00504	CbGeAlD
Lapatinib—ABCB1—lymph node—gallbladder cancer	0.000116	0.00387	CbGeAlD
Lapatinib—ERBB4—DAP12 signaling—HRAS—gallbladder cancer	7.38e-05	0.000667	CbGpPWpGaD
Lapatinib—ERBB2—NGF signalling via TRKA from the plasma membrane—KRAS—gallbladder cancer	7.34e-05	0.000664	CbGpPWpGaD
Lapatinib—EGFR—Signaling by SCF-KIT—ERBB2—gallbladder cancer	7.34e-05	0.000664	CbGpPWpGaD
Lapatinib—ERBB4—Downstream signaling events of B Cell Receptor (BCR)—HRAS—gallbladder cancer	7.27e-05	0.000658	CbGpPWpGaD
Lapatinib—ERBB4—NGF signalling via TRKA from the plasma membrane—KRAS—gallbladder cancer	7.23e-05	0.000654	CbGpPWpGaD
Lapatinib—EGFR—Integrated Breast Cancer Pathway—BCL2—gallbladder cancer	7.15e-05	0.000647	CbGpPWpGaD
Lapatinib—EGFR—ErbB1 downstream signaling—NRAS—gallbladder cancer	7.07e-05	0.00064	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by FGFR in disease—HRAS—gallbladder cancer	7.05e-05	0.000637	CbGpPWpGaD
Lapatinib—ERBB2—DAP12 interactions—HRAS—gallbladder cancer	7.05e-05	0.000637	CbGpPWpGaD
Lapatinib—ERBB2—Fc epsilon receptor (FCERI) signaling—HRAS—gallbladder cancer	7.05e-05	0.000637	CbGpPWpGaD
Lapatinib—EGFR—Downstream signaling of activated FGFR—ERBB2—gallbladder cancer	7.02e-05	0.000635	CbGpPWpGaD
Lapatinib—TAP1—Adaptive Immune System—HRAS—gallbladder cancer	7e-05	0.000633	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by EGFR—HRAS—gallbladder cancer	6.98e-05	0.000632	CbGpPWpGaD
Lapatinib—ERBB4—Fc epsilon receptor (FCERI) signaling—HRAS—gallbladder cancer	6.94e-05	0.000628	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by FGFR in disease—HRAS—gallbladder cancer	6.94e-05	0.000628	CbGpPWpGaD
Lapatinib—ERBB4—DAP12 interactions—HRAS—gallbladder cancer	6.94e-05	0.000628	CbGpPWpGaD
Lapatinib—ERBB2—Integrated Pancreatic Cancer Pathway—TP53—gallbladder cancer	6.93e-05	0.000627	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by EGFR in Cancer—HRAS—gallbladder cancer	6.92e-05	0.000626	CbGpPWpGaD
Lapatinib—EGFR—Signaling by ERBB4—ERBB2—gallbladder cancer	6.91e-05	0.000625	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by PDGF—HRAS—gallbladder cancer	6.89e-05	0.000623	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by EGFR—HRAS—gallbladder cancer	6.88e-05	0.000622	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by EGFR in Cancer—HRAS—gallbladder cancer	6.82e-05	0.000617	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by PDGF—HRAS—gallbladder cancer	6.79e-05	0.000614	CbGpPWpGaD
Lapatinib—ERBB2—Focal Adhesion—HRAS—gallbladder cancer	6.66e-05	0.000602	CbGpPWpGaD
Lapatinib—EGFR—Signaling by NGF—ERBB3—gallbladder cancer	6.65e-05	0.000601	CbGpPWpGaD
Lapatinib—EGFR—Downstream signal transduction—ERBB2—gallbladder cancer	6.6e-05	0.000597	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways in Glioblastoma—TP53—gallbladder cancer	6.59e-05	0.000596	CbGpPWpGaD
Lapatinib—EGFR—EGF/EGFR Signaling Pathway—ERBB2—gallbladder cancer	6.57e-05	0.000594	CbGpPWpGaD
Lapatinib—EGFR—Signaling by FGFR—ERBB2—gallbladder cancer	6.57e-05	0.000594	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by NGF—NRAS—gallbladder cancer	6.56e-05	0.000593	CbGpPWpGaD
Lapatinib—EGFR—Signaling by ERBB2—ERBB2—gallbladder cancer	6.54e-05	0.000591	CbGpPWpGaD
Lapatinib—ERBB2—B Cell Activation—HRAS—gallbladder cancer	6.52e-05	0.00059	CbGpPWpGaD
Lapatinib—EGFR—DAP12 signaling—ERBB2—gallbladder cancer	6.51e-05	0.000588	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by NGF—NRAS—gallbladder cancer	6.46e-05	0.000585	CbGpPWpGaD
Lapatinib—ERBB4—B Cell Activation—HRAS—gallbladder cancer	6.42e-05	0.000581	CbGpPWpGaD
Lapatinib—EGFR—Downstream signaling events of B Cell Receptor (BCR)—ERBB2—gallbladder cancer	6.41e-05	0.00058	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways in Glioblastoma—HRAS—gallbladder cancer	6.3e-05	0.00057	CbGpPWpGaD
Lapatinib—ERBB2—NGF signalling via TRKA from the plasma membrane—HRAS—gallbladder cancer	6.24e-05	0.000564	CbGpPWpGaD
Lapatinib—ERBB4—NGF signalling via TRKA from the plasma membrane—HRAS—gallbladder cancer	6.15e-05	0.000556	CbGpPWpGaD
Lapatinib—EGFR—DAP12 interactions—ERBB2—gallbladder cancer	6.12e-05	0.000554	CbGpPWpGaD
Lapatinib—EGFR—Signaling by FGFR in disease—ERBB2—gallbladder cancer	6.12e-05	0.000554	CbGpPWpGaD
Lapatinib—EGFR—Fc epsilon receptor (FCERI) signaling—ERBB2—gallbladder cancer	6.12e-05	0.000554	CbGpPWpGaD
Lapatinib—EGFR—ErbB1 downstream signaling—KRAS—gallbladder cancer	6.09e-05	0.00055	CbGpPWpGaD
Lapatinib—EGFR—Signaling by EGFR—ERBB2—gallbladder cancer	6.07e-05	0.000549	CbGpPWpGaD
Lapatinib—EGFR—Signaling by EGFR in Cancer—ERBB2—gallbladder cancer	6.01e-05	0.000544	CbGpPWpGaD
Lapatinib—EGFR—Signaling by PDGF—ERBB2—gallbladder cancer	5.99e-05	0.000541	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by NGF—EGFR—gallbladder cancer	5.98e-05	0.000541	CbGpPWpGaD
Lapatinib—EGFR—Focal Adhesion—BCL2—gallbladder cancer	5.95e-05	0.000538	CbGpPWpGaD
Lapatinib—ERBB2—Axon guidance—NRAS—gallbladder cancer	5.94e-05	0.000537	CbGpPWpGaD
Lapatinib—EGFR—Integrated Pancreatic Cancer Pathway—BCL2—gallbladder cancer	5.93e-05	0.000536	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by NGF—EGFR—gallbladder cancer	5.89e-05	0.000533	CbGpPWpGaD
Lapatinib—TAP1—Immune System—NRAS—gallbladder cancer	5.8e-05	0.000525	CbGpPWpGaD
Lapatinib—EGFR—Focal Adhesion—ERBB2—gallbladder cancer	5.78e-05	0.000523	CbGpPWpGaD
Lapatinib—EGFR—Integrated Pancreatic Cancer Pathway—ERBB2—gallbladder cancer	5.76e-05	0.000521	CbGpPWpGaD
Lapatinib—EGFR—B Cell Activation—ERBB2—gallbladder cancer	5.66e-05	0.000512	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by NGF—KRAS—gallbladder cancer	5.65e-05	0.000511	CbGpPWpGaD
Lapatinib—EGFR—Signaling by SCF-KIT—NRAS—gallbladder cancer	5.58e-05	0.000505	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by NGF—KRAS—gallbladder cancer	5.56e-05	0.000503	CbGpPWpGaD
Lapatinib—EGFR—NGF signalling via TRKA from the plasma membrane—ERBB2—gallbladder cancer	5.42e-05	0.00049	CbGpPWpGaD
Lapatinib—ERBB2—Axon guidance—EGFR—gallbladder cancer	5.41e-05	0.000489	CbGpPWpGaD
Lapatinib—EGFR—Immune System—KEAP1—gallbladder cancer	5.38e-05	0.000486	CbGpPWpGaD
Lapatinib—EGFR—Regulation of Actin Cytoskeleton—NRAS—gallbladder cancer	5.34e-05	0.000483	CbGpPWpGaD
Lapatinib—EGFR—Downstream signaling of activated FGFR—NRAS—gallbladder cancer	5.34e-05	0.000483	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—ERBB4—gallbladder cancer	5.28e-05	0.000478	CbGpPWpGaD
Lapatinib—TAP1—Immune System—EGFR—gallbladder cancer	5.28e-05	0.000478	CbGpPWpGaD
Lapatinib—EGFR—Signaling by ERBB4—NRAS—gallbladder cancer	5.26e-05	0.000476	CbGpPWpGaD
Lapatinib—EGFR—ErbB1 downstream signaling—HRAS—gallbladder cancer	5.17e-05	0.000468	CbGpPWpGaD
Lapatinib—ERBB2—Axon guidance—KRAS—gallbladder cancer	5.11e-05	0.000462	CbGpPWpGaD
Lapatinib—ERBB2—Innate Immune System—BCL2—gallbladder cancer	5.06e-05	0.000458	CbGpPWpGaD
Lapatinib—EGFR—Downstream signal transduction—NRAS—gallbladder cancer	5.02e-05	0.000454	CbGpPWpGaD
Lapatinib—EGFR—Signaling by FGFR—NRAS—gallbladder cancer	5e-05	0.000452	CbGpPWpGaD
Lapatinib—TAP1—Immune System—KRAS—gallbladder cancer	4.99e-05	0.000452	CbGpPWpGaD
Lapatinib—ERBB4—Innate Immune System—BCL2—gallbladder cancer	4.99e-05	0.000451	CbGpPWpGaD
Lapatinib—EGFR—Signaling by ERBB2—NRAS—gallbladder cancer	4.97e-05	0.00045	CbGpPWpGaD
Lapatinib—EGFR—DAP12 signaling—NRAS—gallbladder cancer	4.95e-05	0.000448	CbGpPWpGaD
Lapatinib—EGFR—Spinal Cord Injury—TP53—gallbladder cancer	4.93e-05	0.000446	CbGpPWpGaD
Lapatinib—ERBB2—Disease—ERBB4—gallbladder cancer	4.88e-05	0.000441	CbGpPWpGaD
Lapatinib—EGFR—Downstream signaling events of B Cell Receptor (BCR)—NRAS—gallbladder cancer	4.88e-05	0.000441	CbGpPWpGaD
Lapatinib—EGFR—MAPK Signaling Pathway—NRAS—gallbladder cancer	4.85e-05	0.000439	CbGpPWpGaD
Lapatinib—ERBB4—Innate Immune System—ERBB2—gallbladder cancer	4.84e-05	0.000438	CbGpPWpGaD
Lapatinib—EGFR—Signaling by SCF-KIT—KRAS—gallbladder cancer	4.81e-05	0.000435	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by NGF—HRAS—gallbladder cancer	4.8e-05	0.000434	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by NGF—HRAS—gallbladder cancer	4.73e-05	0.000428	CbGpPWpGaD
Lapatinib—EGFR—Fc epsilon receptor (FCERI) signaling—NRAS—gallbladder cancer	4.66e-05	0.000421	CbGpPWpGaD
Lapatinib—EGFR—DAP12 interactions—NRAS—gallbladder cancer	4.66e-05	0.000421	CbGpPWpGaD
Lapatinib—EGFR—Signaling by FGFR in disease—NRAS—gallbladder cancer	4.66e-05	0.000421	CbGpPWpGaD
Lapatinib—ERBB4—Adaptive Immune System—ERBB2—gallbladder cancer	4.65e-05	0.000421	CbGpPWpGaD
Lapatinib—EGFR—Signaling by EGFR—NRAS—gallbladder cancer	4.61e-05	0.000417	CbGpPWpGaD
Lapatinib—EGFR—Downstream signaling of activated FGFR—KRAS—gallbladder cancer	4.6e-05	0.000416	CbGpPWpGaD
Lapatinib—EGFR—Regulation of Actin Cytoskeleton—KRAS—gallbladder cancer	4.6e-05	0.000416	CbGpPWpGaD
Lapatinib—EGFR—Signaling by EGFR in Cancer—NRAS—gallbladder cancer	4.57e-05	0.000414	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—ERBB3—gallbladder cancer	4.57e-05	0.000413	CbGpPWpGaD
Lapatinib—EGFR—Signaling by PDGF—NRAS—gallbladder cancer	4.55e-05	0.000412	CbGpPWpGaD
Lapatinib—EGFR—Integrated Breast Cancer Pathway—KRAS—gallbladder cancer	4.55e-05	0.000412	CbGpPWpGaD
Lapatinib—EGFR—Signaling by ERBB4—KRAS—gallbladder cancer	4.53e-05	0.000409	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—ERBB3—gallbladder cancer	4.5e-05	0.000407	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—ERBB4—gallbladder cancer	4.39e-05	0.000397	CbGpPWpGaD
Lapatinib—ERBB2—Axon guidance—HRAS—gallbladder cancer	4.34e-05	0.000393	CbGpPWpGaD
Lapatinib—EGFR—Downstream signal transduction—KRAS—gallbladder cancer	4.32e-05	0.000391	CbGpPWpGaD
Lapatinib—EGFR—B Cell Activation—NRAS—gallbladder cancer	4.31e-05	0.00039	CbGpPWpGaD
Lapatinib—EGFR—Signaling by FGFR—KRAS—gallbladder cancer	4.3e-05	0.000389	CbGpPWpGaD
Lapatinib—EGFR—EGF/EGFR Signaling Pathway—KRAS—gallbladder cancer	4.3e-05	0.000389	CbGpPWpGaD
Lapatinib—EGFR—Direct p53 effectors—TP53—gallbladder cancer	4.3e-05	0.000389	CbGpPWpGaD
Lapatinib—EGFR—Signaling by ERBB2—KRAS—gallbladder cancer	4.28e-05	0.000387	CbGpPWpGaD
Lapatinib—EGFR—DAP12 signaling—KRAS—gallbladder cancer	4.26e-05	0.000385	CbGpPWpGaD
Lapatinib—TAP1—Immune System—HRAS—gallbladder cancer	4.24e-05	0.000384	CbGpPWpGaD
Lapatinib—ERBB2—Developmental Biology—NRAS—gallbladder cancer	4.24e-05	0.000383	CbGpPWpGaD
Lapatinib—ERBB2—Disease—ERBB3—gallbladder cancer	4.22e-05	0.000382	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—ERBB4—gallbladder cancer	4.21e-05	0.000381	CbGpPWpGaD
Lapatinib—EGFR—Downstream signaling events of B Cell Receptor (BCR)—KRAS—gallbladder cancer	4.2e-05	0.00038	CbGpPWpGaD
Lapatinib—EGFR—MAPK Signaling Pathway—KRAS—gallbladder cancer	4.18e-05	0.000378	CbGpPWpGaD
Lapatinib—EGFR—Signaling by NGF—ERBB2—gallbladder cancer	4.17e-05	0.000377	CbGpPWpGaD
Lapatinib—ERBB4—Disease—ERBB3—gallbladder cancer	4.16e-05	0.000376	CbGpPWpGaD
Lapatinib—EGFR—NGF signalling via TRKA from the plasma membrane—NRAS—gallbladder cancer	4.12e-05	0.000373	CbGpPWpGaD
Lapatinib—EGFR—Signaling by SCF-KIT—HRAS—gallbladder cancer	4.09e-05	0.00037	CbGpPWpGaD
Lapatinib—EGFR—Integrated Breast Cancer Pathway—TP53—gallbladder cancer	4.04e-05	0.000366	CbGpPWpGaD
Lapatinib—EGFR—Signaling by FGFR in disease—KRAS—gallbladder cancer	4.01e-05	0.000362	CbGpPWpGaD
Lapatinib—EGFR—Fc epsilon receptor (FCERI) signaling—KRAS—gallbladder cancer	4.01e-05	0.000362	CbGpPWpGaD
Lapatinib—EGFR—DAP12 interactions—KRAS—gallbladder cancer	4.01e-05	0.000362	CbGpPWpGaD
Lapatinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—gallbladder cancer	3.99e-05	0.00036	CbGpPWpGaD
Lapatinib—EGFR—Signaling by EGFR—KRAS—gallbladder cancer	3.97e-05	0.000359	CbGpPWpGaD
Lapatinib—EGFR—Signaling by EGFR in Cancer—KRAS—gallbladder cancer	3.94e-05	0.000356	CbGpPWpGaD
Lapatinib—EGFR—Signaling by PDGF—KRAS—gallbladder cancer	3.92e-05	0.000354	CbGpPWpGaD
Lapatinib—EGFR—Downstream signaling of activated FGFR—HRAS—gallbladder cancer	3.91e-05	0.000354	CbGpPWpGaD
Lapatinib—ERBB2—Developmental Biology—EGFR—gallbladder cancer	3.86e-05	0.000349	CbGpPWpGaD
Lapatinib—EGFR—Signaling by ERBB4—HRAS—gallbladder cancer	3.85e-05	0.000348	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—ERBB3—gallbladder cancer	3.79e-05	0.000343	CbGpPWpGaD
Lapatinib—EGFR—Axon guidance—ERBB2—gallbladder cancer	3.77e-05	0.000341	CbGpPWpGaD
Lapatinib—EGFR—Integrated Pancreatic Cancer Pathway—KRAS—gallbladder cancer	3.77e-05	0.000341	CbGpPWpGaD
Lapatinib—ERBB2—Innate Immune System—NRAS—gallbladder cancer	3.74e-05	0.000338	CbGpPWpGaD
Lapatinib—EGFR—MAPK Signaling Pathway—TP53—gallbladder cancer	3.71e-05	0.000336	CbGpPWpGaD
Lapatinib—EGFR—B Cell Activation—KRAS—gallbladder cancer	3.71e-05	0.000335	CbGpPWpGaD
Lapatinib—ERBB4—Innate Immune System—NRAS—gallbladder cancer	3.69e-05	0.000333	CbGpPWpGaD
Lapatinib—EGFR—Downstream signal transduction—HRAS—gallbladder cancer	3.67e-05	0.000332	CbGpPWpGaD
Lapatinib—EGFR—EGF/EGFR Signaling Pathway—HRAS—gallbladder cancer	3.66e-05	0.000331	CbGpPWpGaD
Lapatinib—EGFR—Signaling by FGFR—HRAS—gallbladder cancer	3.66e-05	0.000331	CbGpPWpGaD
Lapatinib—ERBB2—Developmental Biology—KRAS—gallbladder cancer	3.65e-05	0.00033	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—ERBB3—gallbladder cancer	3.64e-05	0.000329	CbGpPWpGaD
Lapatinib—EGFR—Signaling by ERBB2—HRAS—gallbladder cancer	3.64e-05	0.000329	CbGpPWpGaD
Lapatinib—EGFR—DAP12 signaling—HRAS—gallbladder cancer	3.62e-05	0.000328	CbGpPWpGaD
Lapatinib—ERBB2—Adaptive Immune System—NRAS—gallbladder cancer	3.59e-05	0.000325	CbGpPWpGaD
Lapatinib—EGFR—Downstream signaling events of B Cell Receptor (BCR)—HRAS—gallbladder cancer	3.57e-05	0.000323	CbGpPWpGaD
Lapatinib—EGFR—NGF signalling via TRKA from the plasma membrane—KRAS—gallbladder cancer	3.55e-05	0.000321	CbGpPWpGaD
Lapatinib—ERBB4—Adaptive Immune System—NRAS—gallbladder cancer	3.54e-05	0.00032	CbGpPWpGaD
Lapatinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—gallbladder cancer	3.43e-05	0.00031	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—ERBB4—gallbladder cancer	3.42e-05	0.000309	CbGpPWpGaD
Lapatinib—ERBB2—Innate Immune System—EGFR—gallbladder cancer	3.41e-05	0.000308	CbGpPWpGaD
Lapatinib—EGFR—Fc epsilon receptor (FCERI) signaling—HRAS—gallbladder cancer	3.41e-05	0.000308	CbGpPWpGaD
Lapatinib—EGFR—Signaling by FGFR in disease—HRAS—gallbladder cancer	3.41e-05	0.000308	CbGpPWpGaD
Lapatinib—EGFR—DAP12 interactions—HRAS—gallbladder cancer	3.41e-05	0.000308	CbGpPWpGaD
Lapatinib—EGFR—Signaling by EGFR—HRAS—gallbladder cancer	3.38e-05	0.000305	CbGpPWpGaD
Lapatinib—ERBB4—Innate Immune System—EGFR—gallbladder cancer	3.36e-05	0.000304	CbGpPWpGaD
Lapatinib—EGFR—Integrated Pancreatic Cancer Pathway—TP53—gallbladder cancer	3.35e-05	0.000303	CbGpPWpGaD
Lapatinib—EGFR—Signaling by EGFR in Cancer—HRAS—gallbladder cancer	3.35e-05	0.000303	CbGpPWpGaD
Lapatinib—EGFR—Signaling by PDGF—HRAS—gallbladder cancer	3.33e-05	0.000301	CbGpPWpGaD
Lapatinib—ERBB2—Adaptive Immune System—EGFR—gallbladder cancer	3.27e-05	0.000296	CbGpPWpGaD
Lapatinib—ERBB4—Adaptive Immune System—EGFR—gallbladder cancer	3.22e-05	0.000292	CbGpPWpGaD
Lapatinib—ERBB2—Innate Immune System—KRAS—gallbladder cancer	3.22e-05	0.000291	CbGpPWpGaD
Lapatinib—EGFR—Focal Adhesion—HRAS—gallbladder cancer	3.22e-05	0.000291	CbGpPWpGaD
Lapatinib—ERBB4—Innate Immune System—KRAS—gallbladder cancer	3.17e-05	0.000287	CbGpPWpGaD
Lapatinib—EGFR—Signaling by NGF—NRAS—gallbladder cancer	3.17e-05	0.000287	CbGpPWpGaD
Lapatinib—EGFR—B Cell Activation—HRAS—gallbladder cancer	3.15e-05	0.000285	CbGpPWpGaD
Lapatinib—ERBB2—Developmental Biology—HRAS—gallbladder cancer	3.1e-05	0.00028	CbGpPWpGaD
Lapatinib—ERBB2—Adaptive Immune System—KRAS—gallbladder cancer	3.09e-05	0.00028	CbGpPWpGaD
Lapatinib—ERBB4—Adaptive Immune System—KRAS—gallbladder cancer	3.05e-05	0.000276	CbGpPWpGaD
Lapatinib—EGFR—NGF signalling via TRKA from the plasma membrane—HRAS—gallbladder cancer	3.02e-05	0.000273	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—gallbladder cancer	2.99e-05	0.000271	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—ERBB3—gallbladder cancer	2.95e-05	0.000267	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—BCL2—gallbladder cancer	2.95e-05	0.000267	CbGpPWpGaD
Lapatinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—gallbladder cancer	2.92e-05	0.000264	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—ERBB3—gallbladder cancer	2.91e-05	0.000263	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—gallbladder cancer	2.91e-05	0.000263	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—BCL2—gallbladder cancer	2.9e-05	0.000263	CbGpPWpGaD
Lapatinib—EGFR—Axon guidance—NRAS—gallbladder cancer	2.87e-05	0.00026	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—ERBB2—gallbladder cancer	2.82e-05	0.000255	CbGpPWpGaD
Lapatinib—ERBB2—Innate Immune System—HRAS—gallbladder cancer	2.74e-05	0.000248	CbGpPWpGaD
Lapatinib—EGFR—Signaling by NGF—KRAS—gallbladder cancer	2.73e-05	0.000247	CbGpPWpGaD
Lapatinib—ERBB4—Innate Immune System—HRAS—gallbladder cancer	2.7e-05	0.000244	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—ERBB2—gallbladder cancer	2.69e-05	0.000244	CbGpPWpGaD
Lapatinib—ERBB2—Adaptive Immune System—HRAS—gallbladder cancer	2.63e-05	0.000238	CbGpPWpGaD
Lapatinib—ERBB4—Disease—ERBB2—gallbladder cancer	2.61e-05	0.000236	CbGpPWpGaD
Lapatinib—ERBB4—Adaptive Immune System—HRAS—gallbladder cancer	2.59e-05	0.000234	CbGpPWpGaD
Lapatinib—EGFR—Immune System—ERBB4—gallbladder cancer	2.55e-05	0.000231	CbGpPWpGaD
Lapatinib—EGFR—Axon guidance—KRAS—gallbladder cancer	2.47e-05	0.000223	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—BCL2—gallbladder cancer	2.45e-05	0.000221	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—ERBB2—gallbladder cancer	2.38e-05	0.000215	CbGpPWpGaD
Lapatinib—EGFR—Disease—ERBB4—gallbladder cancer	2.36e-05	0.000213	CbGpPWpGaD
Lapatinib—EGFR—Signaling by NGF—HRAS—gallbladder cancer	2.32e-05	0.00021	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—ERBB2—gallbladder cancer	2.28e-05	0.000207	CbGpPWpGaD
Lapatinib—EGFR—Immune System—ERBB3—gallbladder cancer	2.21e-05	0.0002	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—NRAS—gallbladder cancer	2.18e-05	0.000197	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—NRAS—gallbladder cancer	2.15e-05	0.000194	CbGpPWpGaD
Lapatinib—EGFR—Axon guidance—HRAS—gallbladder cancer	2.1e-05	0.00019	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—NRAS—gallbladder cancer	2.05e-05	0.000185	CbGpPWpGaD
Lapatinib—EGFR—Disease—ERBB3—gallbladder cancer	2.04e-05	0.000184	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—gallbladder cancer	2.01e-05	0.000182	CbGpPWpGaD
Lapatinib—ERBB2—Disease—NRAS—gallbladder cancer	2.01e-05	0.000182	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—EGFR—gallbladder cancer	1.99e-05	0.00018	CbGpPWpGaD
Lapatinib—ERBB4—Disease—NRAS—gallbladder cancer	1.98e-05	0.000179	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—EGFR—gallbladder cancer	1.96e-05	0.000177	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—gallbladder cancer	1.9e-05	0.000172	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—KRAS—gallbladder cancer	1.88e-05	0.00017	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—KRAS—gallbladder cancer	1.85e-05	0.000167	CbGpPWpGaD
Lapatinib—ERBB2—Disease—EGFR—gallbladder cancer	1.83e-05	0.000166	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—ERBB2—gallbladder cancer	1.82e-05	0.000165	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—NRAS—gallbladder cancer	1.81e-05	0.000164	CbGpPWpGaD
Lapatinib—ERBB4—Disease—EGFR—gallbladder cancer	1.81e-05	0.000163	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—KRAS—gallbladder cancer	1.76e-05	0.000159	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—NRAS—gallbladder cancer	1.74e-05	0.000157	CbGpPWpGaD
Lapatinib—ERBB2—Disease—KRAS—gallbladder cancer	1.73e-05	0.000157	CbGpPWpGaD
Lapatinib—ERBB4—Disease—KRAS—gallbladder cancer	1.71e-05	0.000154	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—gallbladder cancer	1.69e-05	0.000153	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—ERBB4—gallbladder cancer	1.65e-05	0.000149	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—HRAS—gallbladder cancer	1.59e-05	0.000144	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—HRAS—gallbladder cancer	1.57e-05	0.000142	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—KRAS—gallbladder cancer	1.56e-05	0.000141	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—HRAS—gallbladder cancer	1.5e-05	0.000136	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—KRAS—gallbladder cancer	1.5e-05	0.000135	CbGpPWpGaD
Lapatinib—ERBB2—Disease—HRAS—gallbladder cancer	1.47e-05	0.000133	CbGpPWpGaD
Lapatinib—ERBB4—Disease—HRAS—gallbladder cancer	1.45e-05	0.000131	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—ERBB3—gallbladder cancer	1.43e-05	0.000129	CbGpPWpGaD
Lapatinib—EGFR—Immune System—BCL2—gallbladder cancer	1.43e-05	0.000129	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—NRAS—gallbladder cancer	1.41e-05	0.000127	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—NRAS—gallbladder cancer	1.39e-05	0.000126	CbGpPWpGaD
Lapatinib—EGFR—Immune System—ERBB2—gallbladder cancer	1.38e-05	0.000125	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—HRAS—gallbladder cancer	1.32e-05	0.00012	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—EGFR—gallbladder cancer	1.28e-05	0.000116	CbGpPWpGaD
Lapatinib—EGFR—Disease—ERBB2—gallbladder cancer	1.28e-05	0.000116	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—HRAS—gallbladder cancer	1.27e-05	0.000115	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—EGFR—gallbladder cancer	1.26e-05	0.000114	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—KRAS—gallbladder cancer	1.21e-05	0.00011	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—KRAS—gallbladder cancer	1.19e-05	0.000108	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—NRAS—gallbladder cancer	1.15e-05	0.000104	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—TP53—gallbladder cancer	1.08e-05	9.75e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—TP53—gallbladder cancer	1.06e-05	9.6e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—NRAS—gallbladder cancer	1.05e-05	9.53e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—HRAS—gallbladder cancer	1.03e-05	9.33e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—HRAS—gallbladder cancer	1.02e-05	9.19e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—KRAS—gallbladder cancer	9.93e-06	8.98e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—NRAS—gallbladder cancer	9.73e-06	8.8e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—KRAS—gallbladder cancer	9.07e-06	8.2e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—ERBB2—gallbladder cancer	8.95e-06	8.1e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—HRAS—gallbladder cancer	8.44e-06	7.63e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—KRAS—gallbladder cancer	8.37e-06	7.57e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—HRAS—gallbladder cancer	7.71e-06	6.97e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—HRAS—gallbladder cancer	7.12e-06	6.44e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—NRAS—gallbladder cancer	6.81e-06	6.16e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—KRAS—gallbladder cancer	5.86e-06	5.3e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—TP53—gallbladder cancer	5.21e-06	4.71e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—HRAS—gallbladder cancer	4.98e-06	4.51e-05	CbGpPWpGaD
